SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
Report by Issuer of Securities Quoted on The Nasdaq Stock Market
Interdealer Quotation System
Filed pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
ORTHOLOGIC CORP.
(Exact name of issuer as specified in charter)
2850 South 36th Street, Phoenix, Arizona 85034
(Address of principal executive offices)
Issuer's telephone number, including area code: (602) 437-5520
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of shares
outstanding:
1. Title of Security: Common Stock, $.0005 par value
-----------------------------------------------------
2. Number of shares outstanding before the change: 12,490,523
------------------------
3. Number of shares outstanding after the change: 24,980,846
-------------------------
4. Effective date of change: 6/25/96
----------------------------------------------
5. Method of change: Stock split
------------------------------------------------------
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)
Give brief description of transaction: 2-for-1 stock split effected in the form
------------------------------------------
of a 100% stock dividend
------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change:
--------------------------------------------------
2. Name after change:
-----------------------------------------------------
3. Effective date of charter amendment changing name:
---------------------
4. Date of shareholder approval of change, if required:
-------------------
Date: June 28, 1996 /s/ Allen R. Dunaway
------------------ -------------------------------------
Allen R. Dunaway, Vice President,
Chief Financial Officer and Secretary
